| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Glickman Daniel R is a Director at CME. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $3.8M at current prices.
Our model assigns Glickman Daniel R a below-average insider score of 47/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -5.2%.
Glickman Daniel R's largest disclosed position is in CME as Director, worth about $3.8M. The recent filings there lean toward selling, a net 4,050 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | CME Cme Group Inc. | Director | Sell | 650 | $201.44 | $130,937.04 | -4.4% | +7.2% | +36.1% | |
| Aug 9, 2023 | CME Cme Group Inc. | Director | Sell | 750 | $206.09 | $154,565.25 | -4.9% | +2.8% | -0.7% | |
| Aug 31, 2022 | CME Cme Group Inc. | Director | Sell | 500 | $196.39 | $98,193.95 | -3.3% | -10.2% | +4.7% | |
| Mar 1, 2022 | CME Cme Group Inc. | Director | Sell | 750 | $234.30 | $175,725.00 | -5.0% | -14.4% | -19.5% | |
| Aug 17, 2020 | CME Cme Group Inc. | Director | Sell | 900 | $173.22 | $155,898.00 | -5.9% | - | - | |
| Aug 28, 2019 | CME Cme Group Inc. | Director | Sell | 500 | $216.01 | $108,005.00 | -3.3% | - | - |